PUBLIC CONTRACT · 2023
4180089/2023 - Aq.central E587-rilpivirina 25 mg + emtricitabina 200 mg +tenofovir alaf 25 mg comp reves
- Contract value
- €83,688.00
- Signed on
- 6 February 2023
- Procedure
- Ao abrigo de acordo-quadro (art.º 258.º)
This page lays out the fields published on Portal BASE and says when a field is unavailable. It is not an assessment of the contract's merit, legality or impact.
Record 9934930PUBLISHED SUBJECT
4180089/2023 - AQ.CENTRAL E587-RILPIVIRINA 25 MG + EMTRICITABINA 200 MG +TENOFOVIR ALAF 25 MG COMP REVES
WHO CONTRACTED
Parties involved
- Place of performance
- Portugal, Setúbal, Barreiro
- NUTS region
- Not stated
WHO BID
Awardee and competitors
Companies that IMPIC lists as the awardee and as competitors in this procedure.
- Awardee
- GILEAD SCIENCES LDA. · Tax ID 503604704
HOW MUCH AND WHEN
Values and timeline
- Contract price
- €83,688.00
- Procedure base price
- €83,688.00
- Total effective price
- €83,688.00
- Publication date
- 18 April 2023
- Award date
- 6 February 2023
- Signing date
- 6 February 2023
- Performance period
- 3 days
The contract price is the value agreed in the contract, not the amount paid.
HOW IT WAS CONTRACTED
Procedure and framework
- Contract type
- Aquisição de bens móveis
- Procedure type
- Ao abrigo de acordo-quadro (art.º 258.º)
- Award criterion
- Monofator
- CPV code
- 33600000-6 - Produtos farmacêuticos
- Legal basis
- Artigo 258.º do Código dos Contratos Públicos
- Regime
- Código dos Contratos Públicos (DL111-B/2017) e Lei n.º 30/2021, de 21.05
- Framework agreement
- CP 2022/40 - Medicamentos antirretrovíricos para o tratamento da infeção por VIH
- Centralised procedure
- No
- Environmental criterion
- No
- Notice
- Not stated
- Procedure identifier
- 6452189
KEEP EXPLORING
Compare with other contracts
Search the same body, supplier, place or type of service to understand the context of the published index.